The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shumakov D.V.

Vladimirsky Moscow Regional Research Clinical Institute

Shekhyan G.G.

Vladimirsky Moscow Regional Research Clinical Institute

Zybin D.I.

Vladimirsky Moscow Regional Research Clinical Institute

Yalymov A.A.

Vladimirsky Moscow Regional Research Clinical Institute

Vedenikin T.Yu.

Veresaev Moscow City Hospital

Popov M.A.

Vladimirsky Moscow Regional Research Clinical Institute

In-stent restenosis: symptoms, hemodynamic signs, pathogenesis and treatment

Authors:

Shumakov D.V., Shekhyan G.G., Zybin D.I., Yalymov A.A., Vedenikin T.Yu., Popov M.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2021;16(1): 20‑27

DOI: 10.17116/Cardiobulletin20211601120

Read: 14267 times

Download PDF (RU)
Contact the author
Table of contents

IN-STENT RESTENOSIS: SYMPTOMS, HEMODYNAMIC SIGNS, PATHOGENESIS AND TREATMENT
IN-STENT RESTENOSIS: SYMPTOMS, HEMODYNAMIC SIGNS, PATHOGENESIS AND TREATMENT

To cite this article:

Shumakov DV, Shekhyan GG, Zybin DI, Yalymov AA, Vedenikin TYu, Popov MA. In-stent restenosis: symptoms, hemodynamic signs, pathogenesis and treatment. Russian Cardiology Bulletin. 2021;16(1):20‑27. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20211601120

ЭндоКард
Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Endo­scopic methods of treatment of benign stenosis of the trachea. Endo­scopic Surgery. 2024;(5):59-65
Prediction of myocardial contractility after coro­nary bypass surgery acco­rding to preoperative contrast-enhanced cardiac magnetic reso­nance imaging and echo­cardiography data. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):506-511
Prognostic role of frailty in early and long-term prognosis after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):512-518
Cyto­kine profile in middle-aged men with acute and chro­nic coro­nary syndrome and its rela­tion with coro­nary bed lesion seve­rity. Russian Journal of Preventive Medi­cine. 2024;(10):101-107
Reha­bilitation pote­ntial of patients with ischemic heart disease who unde­rwent auto­venous coro­nary artery bypass surgery in the evaluation of reha­bilitation treatment effe­ctiveness. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):29-39
Inde­pendent adve­rse outcomes predictors in patients with stable coro­nary heart disease after sche­duled percutaneous coro­nary inte­rventions. Russian Journal of Preventive Medi­cine. 2024;(11):94-101
Improving an auto­matic stress test analysis protocol as a problem solu­tion for sympatho-dependent arrhythmias identification. Russian Journal of Preventive Medi­cine. 2024;(11):115-121
Cost-effectiveness of using rubi­dium-82 chlo­ride perfusion PET for planning myocardial reva­scularization procedures. Piro­gov Russian Journal of Surgery. 2024;(12-2):58-65
Mode­rate ischemic mitral insu­fficiency with severe left ventricular dysfunction: surgical treatment depe­nding on predictors of adve­rse long-term outcomes. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):651-659
Radionuclide methods in analysis of myocardial perfusion and meta­bolic acti­vity. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):12-19
Abstract:

The widespread use of interventional treatment of atherosclerotic coronary lesions has significantly increased early and long-term safety and effectiveness of percutaneous procedures. At the same time, in-stent restenosis as one of the most undesirable complications occurs in some patients. This review is devoted to clinical manifestations of restenosis, pathogenesis of this process, risk factors and treatment of this adverse event.

Keywords:

percutaneous coronary intervention
stent
drug-eluting stent
in-stent restenosis
coronary artery disease

Authors:

Shumakov D.V.

Vladimirsky Moscow Regional Research Clinical Institute

Shekhyan G.G.

Vladimirsky Moscow Regional Research Clinical Institute

Zybin D.I.

Vladimirsky Moscow Regional Research Clinical Institute

Yalymov A.A.

Vladimirsky Moscow Regional Research Clinical Institute

Vedenikin T.Yu.

Veresaev Moscow City Hospital

Popov M.A.

Vladimirsky Moscow Regional Research Clinical Institute

Received:

02.06.2020

Accepted:

13.11.2020

Close metadata

References:

  1. World Health Organization. WHO Methods and data Sources for Country-Level Causes of Death 2000—2012. Geneva, Switzerland: WHO; 2014. Accessed March 09, 2021. https://www.who.int/healthinfo/global_burden_disease/GlobalCOD_method_2000-2011.pdf?ua=1
  2. Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. European Heart Journal. 2015;36(47):3320-3331. https://doi.org/10.1093/eurheartj/ehv511
  3. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. The New England Journal of Medicine. 1994;331(8):496-501.  https://doi.org/10.1056/NEJM199408253310802
  4. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119(25):3198-3206. https://doi.org/10.1161/CIRCULATIONAHA.108.826479
  5. Cortese B, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, Cremonesi A, Silva PL, Sgueglia GA; Italian Society of Interventional Cardiology. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheterization and Cardiovascular Interventions. 2014;83(3):427-435.  https://doi.org/10.1002/ccd.25149
  6. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. Journal of Thoracic Disease. 2016;8(10):1150-1162. https://doi.org/10.21037/jtd.2016.10.93
  7. Roubin GS, King SB III, Douglas JS Jr. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. The American Journal of Cardiology. 1987;60(3):39-43.  https://doi.org/10.1016/0002-9149(87)90482-6
  8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115(17):2344-2351. https://doi.org/10.1161/CIRCULATIONAHA.106.685313
  9. Cassese S, Byrne RA, Schulz S, Hoppman P, Kreutzer J, Feuchtenberger A, Ibrahim T, Ott I, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A. Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting. European Heart Journal. 2015;36(2):94-99.  https://doi.org/10.1093/eurheartj/ehu383
  10. Bossi I, Klersy C, Black AJ, Cortina R, Choussat R, Cassagneau B, Jordan C, Laborde JC, Laurent JP, Bernies M, Fajadet J, Marco J. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. Journal of the American College of Cardiology. 2000;35(6):1569-1576. https://doi.org/10.1016/s0735-1097(00)00584-2
  11. Nicolais C, Lakhter V, Virk HUH, Sardar P, Bavishi C, O’Murchu B, Chatterjee S. Therapeutic Options for In-Stent Restenosis. Current Cardiology Reports. 2018;20(2):7.  https://doi.org/10.1007/s11886-018-0952-4
  12. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. American Heart Journal. 2006;151(6):1260-1264. https://doi.org/10.1016/j.ahj.2005.08.011
  13. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. Journal of the American College of Cardiology. 2010;56(23):1897-1907. https://doi.org/10.1016/j.jacc.2010.07.028
  14. Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, Escarcega RO, Lipinski MJ, Baker NC, Kitabata H, Ota H, Suddath WO, Satler LF, Pichard AD, Waksman R. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations. Circulation. Cardiovascular Interventions. 2014;7(6):768-776.  https://doi.org/10.1161/CIRCINTERVENTIONS.114.001341
  15. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. Journal of the American College of Cardiology. 2014;63(24):2659-2673. https://doi.org/10.1016/j.jacc.2014.02.545
  16. Pleva L, Kukla P, Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. Journal of Geriatric Cardiology: JGC. 2018;15(2):173-184.  https://doi.org/10.11909/j.issn.1671-5411.2018.02.007
  17. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111(17):2257-2273. https://doi.org/10.1161/01.CIR.0000163587.36485.A7
  18. Omeh DJ. Restenosis. Shlofmitz E, ed. StatPearls Publishing; 2020.
  19. Piek JJ, van der Wal AC, Meuwissen M, Koch KT, Chamuleau SA, Teeling P, van der Loos CM, Becker AE. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. Journal of the American College of Cardiology. 2000;35(4):963-967.  https://doi.org/10.1016/s0735-1097(01)01133-0
  20. Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, Kutys R, Xhepa E, Kastrati A, Virmani R, Joner M. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. European Heart Journal. 2015;36(32):2147-2159. https://doi.org/10.1093/eurheartj/ehv205
  21. Taniwaki M, Windecker S, Räber L. Neoatherosclerosis as reason for stent failures beyond 5 years after drug-eluting stent implantation. European Heart Journal. 2014;35(29):1980. https://doi.org/10.1093/eurheartj/ehv227
  22. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. Journal of the American College of Cardiology. 2008;52(5):333-342.  https://doi.org/10.1016/j.jacc.2008.04.030
  23. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. Journal of the American College of Cardiology. 2011;57(11):1314-1322. https://doi.org/10.1016/j.jacc.2011.01.011
  24. Byrne RA, Joner M, Tada T, Kastrati A. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging. Minerva Cardioangiologica. 2012;60(5):473-489. 
  25. Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, Finn AV, Kolodgie FD, Virmani R. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. European Heart Journal. 2013;34(42):3304-3313. https://doi.org/10.1093/eurheartj/eht241
  26. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, van der Giessen W, Regar E. Optical coherence tomography patterns of stent restenosis. American Heart Journal. 2009;158(2):284-293.  https://doi.org/10.1016/j.ahj.2009.06.004
  27. Looser PM, Kim LK, Feldman DN. In-Stent Restenosis: Pathophysiology and Treatment. Current Treatment Options in Cardiovascular Medicine. 2016;18(2):10.  https://doi.org/10.1007/s11936-015-0433-7
  28. Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC. Cardiovascular Imaging. 2009;2(5):625-628.  https://doi.org/10.1016/j.jcmg.2009.01.011
  29. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL, Kastrati A. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 2014;100(2):153-159.  https://doi.org/10.1136/heartjnl-2013-304933
  30. Rathore S, Terashima M, Katoh O, Matsuo H, Tanaka N, Kinoshita Y, Kimura M, Tuschikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention. 2009;5(3):349-354.  https://doi.org/10.4244/v5i3a55
  31. Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, Dirschinger J, Schomig A. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation. 2006;113(19):2293-2300. https://doi.org/10.1161/CIRCULATIONAHA.105.601823
  32. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann FJ, Sattelberger U, Schmitt C, Muller M, Dirschinger J, Schomig A. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. Journal of the American College of Cardiology. 2003;41(8):1283-1288. https://doi.org/10.1016/s0735-1097(03)00119-0
  33. Fröbert O, Lagerqvist B, Carlsson J, Lindbäck J, Stenestrand U, James SK. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). Journal of the American College of Cardiology. 2009;53(18):1660-1667. https://doi.org/10.1016/j.jacc.2009.01.054
  34. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. Journal of the American College of Cardiology. 1998;32(3):584-589.  https://doi.org/10.1016/s0735-1097(98)00286-1
  35. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. Journal of the American College of Cardiology. 1996;27(3):528-535.  https://doi.org/10.1016/0735-1097(95)00496-3
  36. MacRury SM, Lowe GD. Blood rheology in diabetes mellitus. Diabetic Medicine. 1990;7(4):285-291.  https://doi.org/10.1111/j.1464-5491.1990.tb01391.x
  37. Ostermann H, van de Loo J. Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Haemostasis. 1986;16(6):386-416.  https://doi.org/10.1159/000215317
  38. Murcia AM, Fallon JT, Fuster V. Smooth muscle cell proliferation does not account for restenosis in diabetic patients. Circulation. 1196;94:I619-I620. https://doi.org/10.21037/jtd.2016.10.93
  39. Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Coronary Artery Disease. 2015;26(1):5-10.  https://doi.org/10.1097/MCA.0000000000000170
  40. Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Camilla T, Vado A, Benetton G, Uslenghi E, Piazza A. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 1998;97(2):147-154.  https://doi.org/10.1161/01.cir.97.2.147
  41. Vogiatzi K, Apostolakis S, Voudris V, Thomopoulou S, Kochiadakis GE, Spandidos DA. Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis. 2010;29(1):134-140.  https://doi.org/10.1007/s11239-009-0338-y
  42. Richardson A, Kaye SB. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance. Drug Resistance Updates. 2005;8(5):311-321.  https://doi.org/10.1016/j.drup.2005.09.001
  43. Moreno PR, Bernardi VH, López-Cuéllar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation. 1996;94(12):3098-3102. https://doi.org/10.1161/01.cir.94.12.3098
  44. Neumann FJ, Ott I, Gawaz M, Puchner G, Schömig A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. Journal of the American College of Cardiology. 1996;27(4):819-824.  https://doi.org/10.1016/0735-1097(95)00563-3
  45. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D’Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21(3):327-334.  https://doi.org/10.1161/01.atv.21.3.327
  46. Iijima R, Byrne RA, Ndrepepa G, Braun S, Mehilli J, Berger PB, Schomig A, Kastrati A. Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart. 2009;95(2):107-112.  https://doi.org/10.1136/hrt.2008.153635
  47. Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schuhlen H, Schomig A, Kastrati A. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. American Heart Journal. 2005;150(2):344-350.  https://doi.org/10.1016/j.ahj.2004.09.030
  48. Katsaros KM, Wiesbauer F, Speidl WS, Kastl SP, Huber K, Zorn G, Niessner A, Glogar D, Maurer G, Wojta J. High soluble Fas and soluble Fas ligand serum levels before stent implantation are protective against restenosis. Thrombosis and Haemostasis. 2011;105(5):883-891.  https://doi.org/10.1160/TH10-09-0566
  49. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109(9):1085-1088. https://doi.org/10.1161/01.CIR.0000121327.67756.19
  50. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 2004;110(22):3430-3434. https://doi.org/10.1161/01.CIR.0000148371.53174.05
  51. Costa JR Jr, Sousa A, Moreira AC, Costa RA, Cano M, Maldonado G, Campos C, Carballo M, Pavanello R, Sousa JE. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry. JACC. Cardiovascular Interventions. 2010;3(1):12-18.  https://doi.org/10.1016/j.jcin.2009.10.022
  52. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, Colombo A, Hamm C, Bartorelli A, Rothman M, Nobuyoshi M, Yamaguchi T, Voudris V, DiMario C, Makovski S, Hausmann D, Rowe S, Rabinovich S, Sunamura M, van Es GA. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). European Heart Journal. 1998;19(8):1214-1223. https://doi.org/10.1053/euhj.1998.1012
  53. Pepine CJ, Hirshfeld JW, Macdonald RG, Henderson MA, Bass TA, Goldberg S, Savage MP, Vetrovec G, Cowley M, Taussig AS. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. Circulation. 1990;81(6):1753-1761. https://doi.org/10.1161/01.cir.81.6.1753
  54. Hillegass WB, Ohman EM, Leimberger JD, Califf RM. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. The American Journal of Cardiology. 1994;73(12):835-839.  https://doi.org/10.1016/0002-9149(94)90805-2
  55. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87-165.  https://doi.org/10.1093/ejcts/ezy289
  56. Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schömig A, Kastrati A; ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. Journal of the American College of Cardiology. 2010;55(24):2710-2716. https://doi.org/10.1016/j.jacc.2010.02.009
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.